Mara Renewables Secures $9.1M for Fish-Free Omega-3 Made With Precision Fermentation

Mara Renewables, a biotechnology company specializing in algae-based solutions for human and animal nutrition, has secured $9.1 million in funding from S2G Investments. The company plans to use the funds to expand its sustainable omega-3 platform, increase its research and development capacity, and address critical gaps in global nutrition supply chains. Mara has developed a fish-free alternative to conventional omega-3 supplements using precision fermentation, aiming to provide a reliable and high-quality source of omega-3 while reducing pressure on marine ecosystems.

The company's products, which include algal DHA, have been shown to deliver scientifically proven health benefits and have applications in infant formula, dietary supplements, functional foods, animal health, and more. Mara plans to strengthen its global manufacturing footprint through strategic partnerships, support customers in developing easy-to-consume products for human nutrition, and deepen its commercial collaborations across key global markets. Omega-3 DHA plays a crucial role in maintaining overall health, but the supply from wild-caught fish is insufficient to meet rising demand, presenting Mara with an opportunity to close the gap sustainably and help protect aquatic ecosystems.